Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 2Urogenital Neoplasms 1Sarcoma 1Pancreatic Neoplasms 1Neoplasms 1Gastrointestinal Neoplasms 1Fatigue 1Erectile Dysfunction 1Cholangiocarcinoma 1Breast Neoplasms 1

Interventions

Therapeutics 5Yoga 4Early Intervention, Educational 4Palliative Care 3Acceptance and Commitment Therapy 3regorafenib 2Walking 2Exercise Therapy 2Educational Status 2Counseling 2methyl hydroxyethyl cellulose 1Urinalysis 1Uncertainty 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sodium Chloride 1Sildenafil Citrate 1Restraint, Physical 1Radiotherapy 1Psychosocial Intervention 1Psychiatric Rehabilitation 1Proton Pump Inhibitors 1Physical Therapy Modalities 1Patient Reported Outcome Measures 1Neuropsychological Tests 1Muscle Stretching Exercises 1Methylphenidate 1Methods 1Interviews as Topic 1High-Intensity Interval Training 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fatigue × Sildenafil Citrate × Gastrointestinal × Clear all
NCT02106871 2017-10-27

PCC

The University of Texas Medical Branch, Galveston

Phase 1 Withdrawn
Gastrointestinal

Fatigue, Neoplasms, Pancreatic Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡